Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Wu, Jianmin

Class:IdPerson:3215020
_displayNameWu, Jianmin
_timestamp2013-03-14 03:01:22
created[InstanceEdit:3214964] May, B, 2013-03-14
firstnameJianmin
initialJ
surnameWu
(author)[LiteratureReference:3214945] Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites
[LiteratureReference:9674745] Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
[LiteratureReference:9843053] Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells
[LiteratureReference:9925081] miR-340: A multifunctional role in human malignant diseases
[Change default viewing format]
No pathways have been reviewed or authored by Wu, Jianmin (3215020)